Author/Authors :
Julian Safir MD، نويسنده , , Joseph L. Zito MD، نويسنده , , Mark E. Gershwind MD، نويسنده , , David Faegenburg MD، نويسنده , , Corinne E. Tobin MD، نويسنده , , Paul D. Cayea MD، نويسنده , , William J. Wortman MD، نويسنده , , Lisa M. Sclafani MD، نويسنده , , Virginia E. Maurer MD، نويسنده ,
Abstract :
The diagnois and treatment of breast cancer are dependent upon early detection of the disease by physical examination and mammography. Although mammography is a relatively good and cost-effective method of early breast cancer detection, there are some inherent weaknesses associated with this imaging modality that limit its sensitivity and specificity. Contrast-enhanced MRI of the breasts provides the additional capability to answer questions raised or unanswered with conventional imaging methods. This paper reviews contrast-enhanced breast MRI interpretation guidelines and patient preselection criteria for diagnostic problem cases. Technical aspects using a commercially available three-dimensional (3D) spoiled gradient-echo technique are discussed.
Keywords :
Staging , breast neoplasms , Postoperative , breast neoplasms , diagnosis , breast neoplasms , MR , magnetic resonance , Breastneoplasms , MR contrast enhancement
